KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

HCA Healthcare (HCA) Shares Outstanding (Weighted Average) (2016 - 2026)

HCA Healthcare (HCA) has disclosed Shares Outstanding (Weighted Average) for 17 consecutive years, with $223.6 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding (Weighted Average) fell 9.46% year-over-year to $223.6 million; the TTM value through Mar 2026 reached $223.6 million, down 9.46%, while the annual FY2025 figure was $236.4 million, 8.58% down from the prior year.
  • Shares Outstanding (Weighted Average) hit $223.6 million in Q1 2026 for HCA Healthcare, down from $236.4 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $302.4 million in Q1 2022 and bottomed at $223.6 million in Q1 2026.
  • Average Shares Outstanding (Weighted Average) over 5 years is $265.0 million, with a median of $264.4 million recorded in 2024.
  • Year-over-year, Shares Outstanding (Weighted Average) decreased 10.7% in 2022 and then decreased 3.84% in 2024.
  • HCA Healthcare's Shares Outstanding (Weighted Average) stood at $290.3 million in 2022, then decreased by 6.18% to $272.4 million in 2023, then decreased by 5.07% to $258.6 million in 2024, then fell by 8.58% to $236.4 million in 2025, then dropped by 5.42% to $223.6 million in 2026.
  • According to Business Quant data, Shares Outstanding (Weighted Average) over the past three periods came in at $223.6 million, $236.4 million, and $239.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.